Genzyme Therapeutics
2. Meroni M, Sessa A, Battini G, Tazzari S, Torri Tarelli L. Kidney involvement in Anderson-Fabry disease. Contrib Nephrol 1997; 122:178-84.
3. Mendez MF, Stanley TM, Mendel NM, Li Z, Tedesco DT. The vascular dementia of Fabry’s disease. Dement Geriatr Cogn Disord 1997; 8:252-7.
4. Spence MW, MacKinnon KE, Burgess JK, et al. Failure to correct the metabolic defect by renal allotransplantion in Fabry’s disease. Ann Intern Med 1976; 84:13-6.
5. Kolodny EH. Fabry disease. In: Bogousslavsky J, Caplan L, eds. Stroke Syndromes. New York: Cambridge University Press. 1995. 453-59.
6. Tsakiris D. Rare diseases in renal replacement therapy in the ERA-EDTA Registry. Nephrology Dialysis Transplantation 1996; Vol 11:4-20
7. Lockman LA, Hunninghake DB, Krivit W, Desnick RJ. Relief of pain of Fabry’s disease by diphenylhydantoin. Neurology 1973; 28:871-5.
8. Goldman ME, Cantor R, Schwartz MF, Baker M, Desnick RJ. Echocardiographic abnormalities and disease severity in Fabry’s disease. F Am Coll Cardiol 1986; 7:1157-61.
9. Newton JA, McGibbon DH. The treatment of multiple angiokeratoma with the argon laser. Clin Exp Dermatol 12:23, 1987.
10. Hobbs ER, Ratz JL. Argon laser treatment of angiokeratomas. F Dermatol Surg Oncol 13:1319, 1987.
